Prime Therapeutics

Prime/MRx is proud to support the Americans with Disabilities Act (ADA). On July 26th, we acknowledge this important civil rights law that prohibits discrimination against individuals with disabilities in all areas of public life, including jobs, schools, transportation and all public and private places that are open to the general public. The purpose of the ADA is to make sure that people with disabilities have the same rights and opportunities as everyone else. At Prime/MRx, we recently earned a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion. "This score highlights our commitment to disability inclusion and broader diversity, equity and inclusion initiatives,” says Zabrina Watkins, diversity, equity and inclusion director. “We know that more than 1.3 billon people live with a disability worldwide and want to ensure our workplace is inclusive to everyone." Read more about the Disability Equality Index here: https://bit.ly/3zIcTJH

Take advantage of this quarter's clinical insights and competitive intelligence to stay ahead of the ever-evolving market. Access the quarterly drug pipeline here: https://bit.ly/3SlkTXi

In 2023, we shared leading-edge research about the use of glucagon-like peptide-1 (GLP-1) agonist drugs for weight loss at the one-year mark. Our clinical team recently released year-two findings that indicate lower persistence and adherence and more individuals who switch GLP-1 medications throughout their treatment journey. Learn more about the research and what it means: https://bit.ly/3WdWkOC

Mark your calendars for July 31! Hear from Nathan Downhour, SVP of pharmacy and care solutions, and Linsey Krueger, AVP of strategic partnerships, as they take a deeper look at Pharmacy Match, our new technology-driven solution that helps reduce drug costs through an expanded network of specialty pharmacies. Explore how Pharmacy Match enhances our distinctive conflict-free model for the prescription drug supply chain. And hear how this new solution offers members access to a broader range of high-quality specialty pharmacies, reduces reliance on individual partners and creates real-time competition for better cost management. Register here: https://bit.ly/4ddUUtc

At Prime/MRx, we strive to provide the same care we would want for our loved ones. This purpose extends beyond our employees to encompass our members, clients and communities. In today’s Power of People edition of Pharmacy Friends, we talk about how our employees help goes beyond our work in health care. On any given day, Prime’s people can be found serving others in the communities where we live and work. Kerry Florian, SPHR, MSOL, vice president, total rewards, talks about Prime’s community giving program, PrimeCares, which brings employees together to donate, volunteer and participate in community events. She also talks about working with our communities to address inequality and injustice in all its manifestations, particularly racism, poverty, health and hunger through the Prime Together Foundation. And today’s guest Rebecca DeRosia senior development officer, Hennepin Healthcare Foundation, talks about their great purpose of healing and enriching life in our community and how organizations like the Prime Together Foundation are instrumental in their work. Listen to the episode here: https://bit.ly/3xTQqZL

Today’s the day! The latest Magellan Rx Management report is here, providing you with insights on the industry’s most innovative and groundbreaking managed care solutions for some the most complex areas of health care you’re navigating today. Read the full report for updates on new drugs and strategies to treat PNH, PAH, NASH and MS, upcoming IRA provisions, Star Ratings measures, the obesity epidemic, AI implications for health care and much more. Access the report here: https://bit.ly/3zPoCGd

Check out the latest Oncology Insights article from Simone Ndujiuba, PharmD, BCOP as she discusses the key findings from this year’s American Society of Clinical Oncology (ASCO) Annual Meeting. Learn more here: https://bit.ly/3SePnKM

Get ready for a power-packed session at Specialty Summit 2024 as we host the extraordinary Ben Nemtin. As the #1 The New York Times bestselling author of “What Do You Want To Do Before You Die?”, an unforgettable presence on MTV's “The Buried Life” and a firm believer in limitless potential, Ben's mission is to ignite the spark of “we can” within all of us. Ben possesses an unshakable belief that we can all achieve the impossible, and his experiences have borne witness to the life-changing power of this belief. Prepare to discover your own capabilities, as his words inspire and transform! Learn more and register here for this exciting event: https://bit.ly/3TO5NcM

Our newest High-Cost Therapy profile has arrived. Our experts offer a more detailed look here: https://bit.ly/4cNAMOK

Real-world data is central to discussions about affordability and access, especially as the popularity of glucagon-like peptide-1 (GLP-1) agonist drugs for weight loss continue to climb. But so are comprehensive management strategies. Chief Clinical Officer David Lassen shares more about how Prime continues to lead the industry with our new analysis of integrated pharmacy and medical claims data pertaining to GLP-1 use at the two-year mark. Read more here: https://bit.ly/3WdWkOC